Advertisement

Insect Cell-Based Recombinant Protein Production

  • W. Weber
  • M. Fussenegger
Part of the Principles and Practice book series (PRINCIPLES)

Abstract

Insect cells in conjunction with the baculovirus expression vector (BEV) system represent a fast and efficient system for the generation of recombinant tool proteins (mg- to g-range). This is quite evident from scores of application reports which have been published since 1970. Moreover, the European approval of the vaccine Cervarix (for cervical cancer) from Glaxo SmithKline in autumn 2007 and the development of further potential product candidates (e.g. influenza vaccine FluBIok from Protein Sciences Inc.) indicate the growing industrial interest in commercial use of the BEV/insect cell culture system for manufacture of biopharmaceuticals.

Starting with a short description of main characteristics of insect cells, this chapter delineates generation methods of recombinant virus, the scale-up to protein production (suitable bioreactors and optimum process design), application examples and current trends in insect cell-based protein production. Finally, pros and cons of the BEV/insect cell culture system are summarized.

Keywords

Insect Cell Recombinant Protein Production Infectious Bursal Disease Virus Insect Cell Line Baculovirus Expression System 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ailor E, Betenbaugh MJ (1999) Modifying secretion and post-translational processing in insect cells. Curr Opin Biotechnol 10:142–145CrossRefPubMedGoogle Scholar
  2. Bahia D, Cheung R, Buchs M, Geisse S, Hunt I (2005) Optimisation of insect cell growth in deepwell blocks: development of a high-throughput insect cell expression screen. Protein Expr Purif 39:61–70CrossRefPubMedGoogle Scholar
  3. Bedard C, Kamen A, Tom R, Massie B (1994) Maximization of recombinant protein yield in the insect cell/baculovirus system by one-time addition of nutrients to high-density batch cultures. Cytotechnology 15:129–138CrossRefPubMedGoogle Scholar
  4. Berger I, Fitzgerald DJ, Richmond TJ (2004a) Baculovirus expression system for heterologous multiprotein complexes. Nat Biotechnol 22:1583–1587CrossRefPubMedGoogle Scholar
  5. Berger I, Fitzgerald DJ, Richmond TJAG (2004b) Baculovirus expression system for heterologous multiprotein complexes. Nat Biotechnol 22:1583–1587CrossRefPubMedGoogle Scholar
  6. Brank AS, Van Bemmel DM, Christman JK (2002) Optimization of baculovirus-mediated expression and purification of hexahistidine-tagged murine DNA (cytosine-C5)-methyltransferase-1 in Spodoptera frugiperda 9 cells. Protein Expr Purif 25:31–40CrossRefPubMedGoogle Scholar
  7. Cruz PE, Cunha A, Peixoto CC, Clemente J, Moreira JL, Carrondo MJ (1998) Optimization of the production of virus-like particles in insect cells. Biotechnol Bioeng 60:408–418CrossRefPubMedGoogle Scholar
  8. Cruz PE, Martins PC, Alves PM, Peixoto CC, Santos H, Moreira JL, Carrondo MJ (1999) Proteolytic activity in infected and noninfected insect cells: degradation of HIV-1 Pr55gag particles. Biotechnol Bioeng 65:133–143CrossRefPubMedGoogle Scholar
  9. Elias CB, Zeiser A, Bedard C, Kamen AA (2000) Enhanced growth of Sf-9 cells to a maximum density of 5.2 × 10(7) cells per mL and production of beta-galactosidase at high cell density by fed batch culture. Biotechnol Bioeng 68:381–388CrossRefPubMedGoogle Scholar
  10. Gao X, Yo P, Harris TK (2005) Improved yields for baculovirus-mediated expression of human His(6)-PDK1 and His(6)-PKBbeta/Akt2 and characterization of phospho-specific isoforms for design of inhibitors that stabilize inactive conformations. Protein Expr Purif 43:44–56CrossRefPubMedGoogle Scholar
  11. Geisse S, Gram H, Kleuser B, Kocher HP (1996) Eukaryotic expression systems: a comparison. Protein Expr Purif 8:271–282CrossRefPubMedGoogle Scholar
  12. Guttieri MC, Liang M (2004) Human antibody production using insect-cell expression systems. Methods Mol Biol 248:269–299PubMedGoogle Scholar
  13. Hodoniczky J, Zheng YZ, James DC (2005) Control of recombinant monoclonal antibody effector functions by Fc N-glycan remodeling in vitro. Biotechnol Prog 21:1644–1652CrossRefPubMedGoogle Scholar
  14. Hollister J, Grabenhorst E, Nimtz M, Conradt H, Jarvis DL (2002) Engineering the protein N-glycosylation pathway in insect cells for production of biantennary, complex N-glycans. Biochemistry 41:15093–15104CrossRefPubMedGoogle Scholar
  15. Hu YC, Bentley WE (1999) Enhancing yield of infectious Bursal disease virus structural proteins in baculovirus expression systems: focus on media, protease inhibitors, and dissolved oxygen. Biotechnol Prog 15:1065–1071CrossRefPubMedGoogle Scholar
  16. Ikonomou L, Bastin G, Schneider YJ, Agathos SN (2001) Design of an efficient medium for insect cell growth and recombinant protein production. In Vitro Cell Dev Biol Anim 37:549–559CrossRefPubMedGoogle Scholar
  17. Ikonomou L, Schneider YJ, Agathos SN (2003) Insect cell culture for industrial production of recombinant proteins. Appl Microbiol Biotechnol 62:1–20CrossRefPubMedGoogle Scholar
  18. Jarvis DL (2003) Developing baculovirus-insect cell expression systems for humanized recombinant glycoprotein production. Virology 310:1–7CrossRefPubMedGoogle Scholar
  19. Kamen A, Bedard C, Tom R, Perret S, Jardin B (1996) On-line monitoring of respiration in recombinant baculovirus-infected and uninfected cell bioreactor cultures. Biotechnol Bioeng 50:36–48CrossRefPubMedGoogle Scholar
  20. Kim YK, Shin HS, Tomiya N, Lee YC, Betenbaugh MJ, Cha HJ (2005) Production and N-glycan analysis of secreted human erythropoietin glycoprotein in stably transfected Drosophila S2 cells. Biotechnol Bioeng 92:452–461CrossRefPubMedGoogle Scholar
  21. King LA, Possee RD (1992) The baculovirus expression system. Chapman & Hall, LondonGoogle Scholar
  22. CH, Swarts HG, De Pont JJ (1995) Ethanol stimulates expression of functional H+,K(+)- ATPase in SF9 cells. Biochem Biophys Res Commun 210:907–913CrossRefPubMedGoogle Scholar
  23. Kost TA, Condreay JP, Jarvis DL (2005) Baculovirus as versatile vectors for protein expression in insect and mammalian cells. Nat Biotechnol 23:567–575CrossRefPubMedGoogle Scholar
  24. Kwon MS, Dojima T, Toriyama M, Park EY (2002) Development of an antibody-based assay for determination of baculovirus titers in 10 hours. Biotechnol Prog 18:647–651CrossRefPubMedGoogle Scholar
  25. Legardinier S, Duonor-Cerutti M, Devauchelle G, Combarnous Y, Cahoreau C (2005) Biological activities of recombinant equine luteinizing hormone/chorionic gonadotropin (eLH/CG) expressed in Sf9 and Mimic insect cell lines. J Mol Endocrinol 34:47–60CrossRefPubMedGoogle Scholar
  26. Licari P, Bailey JE (1992) Modeling the population dynamics of baculovirus-infected insect cells: optimizing infection strategies for enhanced recombinant protein yields. Biotechnol Bioeng 39:432–441CrossRefPubMedGoogle Scholar
  27. Liebmann JM, LaScala D, Wang W, Steed PM (1999) When less is more: enhanced baculovirus production of recombinant proteins at very low multiplicities of infection. BioTechniques 26:36–42Google Scholar
  28. Lo HR, Chao YC (2004) Rapid titer determination of baculovirus by quantitative real-time polymerase chain reaction. Biotechnol Prog 20:354–360CrossRefPubMedGoogle Scholar
  29. Maranga L, Brazao TF, Carrondo MJ (2003) Virus-like particle production at low multiplicities of infection with the baculovirus insect cell system. Biotechnol Bioeng 84:245–253CrossRefPubMedGoogle Scholar
  30. Palomares LA, Gonzalez M, Ramirez OT (2000) Evidence of Pluronic F-68 direct interaction with insect cells: impact on shear protection, recombinant protein, and baculovirus production. Enzyme Microb Technol 26:324–331CrossRefPubMedGoogle Scholar
  31. Palomares LA, Joosten CE, Hughes PR, Granados RR, Shuler ML (2003) Novel insect cell line capable of complex N-glycosylation and sialylation of recombinant proteins. Biotechnol Prog 19:185–192CrossRefPubMedGoogle Scholar
  32. Philipps B, Rotmann D, Wicki M, Mayr LM, Forstner M (2005) Time reduction and process optimization of the baculovirus expression system for more efficient recombinant protein production in insect cells. Protein Expr Purif 42:211–218CrossRefPubMedGoogle Scholar
  33. Power JF, Reid S, Radford KM, Greenfield PF, Nielsen LK (1994) Modeling and optimization of the baculovirus expression vector system in batch suspension culture. Biotechnol Bioeng 44:710–719CrossRefPubMedGoogle Scholar
  34. Pyle LE, Barton P, Fujiwara Y, Mitchell A, Fidge N (1995) Secretion of biologically active human proapolipoprotein A-I in a baculovirus-insect cell system: protection from degradation by protease inhibitors. J Lipid Res 36:2355–2361PubMedGoogle Scholar
  35. Sarafanov AG, Makogonenko EM, Pechik IV, Radtke KP, Khrenov AV, Ananyeva NM, Strickland DK, Saenko EL (2006) Identification of coagulation factor VIII A2 domain residues forming the binding epitope for low-density lipoprotein receptor-related protein. Biochemistry 45:1829–1840CrossRefPubMedGoogle Scholar
  36. Schlaeger EJ (1996) Medium design for insect cell culture. Cytotechnology 20:57–70CrossRefGoogle Scholar
  37. Tomiya N, Betenbaugh MJ, Lee YC (2003) Humanization of lepidopteran insect-cell-produced glycoproteins. Acc Chem Res 36:613–620CrossRefPubMedGoogle Scholar
  38. Vialard JE, Arif BM, Richardson CD (1995) Introduction to the molecular biology of baculoviruses. Methods Mol Biol 39:1–24PubMedGoogle Scholar
  39. Viswanathan K, Lawrence S, Hinderlich S, Yarema KJ, Lee YC, Betenbaugh MJ (2003) Engineering sialic acid synthetic ability into insect cells: identifying metabolic bottlenecks and devising strategies to overcome them. Biochemistry 42:15215–15225CrossRefPubMedGoogle Scholar
  40. Weber W, Fussenegger M (2005) Baculovirus-based Production of Biopharmaceuticals using Insect Cell Culture Processes. In “Modern Biopharmaceuticals”, J. Knäblein (ed). Wiley-VCH, Weinheim, Germany, 1045–1062CrossRefGoogle Scholar
  41. Weber W, Weber E, Geisse S, Memmert K (2001) Catching the Wave: the BEVS and the Biowave. In “From target to market”, Lindner-Olsson, E., Chatzissavidou, N., and Lüllau, E. (ed.) Kluwer academic publishers, 335–337Google Scholar
  42. Weber W, Weber E, Geisse S, Memmert K (2002) Optimization of protein expression and establishment of the Wave bioreactor for baculovirus/insect cell culture. Cytotechnology 38:77–85CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2009

Authors and Affiliations

  • W. Weber
    • 1
  • M. Fussenegger
    • 1
  1. 1.Department of Biosystems Science and EngineeringETH ZurichBaselSwitzerland

Personalised recommendations